Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1998 Sep;91(9):475–478. doi: 10.1177/014107689809100906

Hormone replacement therapy and cardioprotection in the elderly.

A Pines 1, H Kessel 1, V Mijatovic 1, M J van der Mooren 1
PMCID: PMC1296875  PMID: 9849518

Full text

PDF
475

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alfie J., Lugones L., Belardo A., Tutzer M., Galarza C. R., Waisman G. D., Cámera M. I. Hemodynamic effects of transdermal estradiol alone and combined with norethisterone acetate. Maturitas. 1997 Jun;27(2):163–169. doi: 10.1016/s0378-5122(97)00030-3. [DOI] [PubMed] [Google Scholar]
  2. Bush T. L., Barrett-Connor E., Cowan L. D., Criqui M. H., Wallace R. B., Suchindran C. M., Tyroler H. A., Rifkind B. M. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 1987 Jun;75(6):1102–1109. doi: 10.1161/01.cir.75.6.1102. [DOI] [PubMed] [Google Scholar]
  3. Collins P., Rosano G. M., Sarrel P. M., Ulrich L., Adamopoulos S., Beale C. M., McNeill J. G., Poole-Wilson P. A. 17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation. 1995 Jul 1;92(1):24–30. doi: 10.1161/01.cir.92.1.24. [DOI] [PubMed] [Google Scholar]
  4. Ettinger B., Friedman G. D., Bush T., Quesenberry C. P., Jr Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol. 1996 Jan;87(1):6–12. doi: 10.1016/0029-7844(95)00358-4. [DOI] [PubMed] [Google Scholar]
  5. Falkeborn M., Persson I., Adami H. O., Bergström R., Eaker E., Lithell H., Mohsen R., Naessén T. The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement. Br J Obstet Gynaecol. 1992 Oct;99(10):821–828. doi: 10.1111/j.1471-0528.1992.tb14414.x. [DOI] [PubMed] [Google Scholar]
  6. Folsom A. R., Mink P. J., Sellers T. A., Hong C. P., Zheng W., Potter J. D. Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women. Am J Public Health. 1995 Aug;85(8 Pt 1):1128–1132. doi: 10.2105/ajph.85.8_pt_1.1128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Grodstein F., Stampfer M. J., Manson J. E., Colditz G. A., Willett W. C., Rosner B., Speizer F. E., Hennekens C. H. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med. 1996 Aug 15;335(7):453–461. doi: 10.1056/NEJM199608153350701. [DOI] [PubMed] [Google Scholar]
  8. Gruchow H. W., Anderson A. J., Barboriak J. J., Sobocinski K. A. Postmenopausal use of estrogen and occlusion of coronary arteries. Am Heart J. 1988 May;115(5):954–963. doi: 10.1016/0002-8703(88)90063-4. [DOI] [PubMed] [Google Scholar]
  9. Handa V. L., Landerman R., Hanlon J. T., Harris T., Cohen H. J. Do older women use estrogen replacement? Data from the Duke Established Populations for Epidemiologic Studies of the Elderly (EPESE) J Am Geriatr Soc. 1996 Jan;44(1):1–6. doi: 10.1111/j.1532-5415.1996.tb05630.x. [DOI] [PubMed] [Google Scholar]
  10. Hong M. K., Romm P. A., Reagan K., Green C. E., Rackley C. E. Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women. Am J Cardiol. 1992 Jan 15;69(3):176–178. doi: 10.1016/0002-9149(92)91300-s. [DOI] [PubMed] [Google Scholar]
  11. Kawano H., Motoyama T., Kugiyama K., Hirashima O., Ohgushi M., Fujii H., Ogawa H., Yasue H. Gender difference in improvement of endothelium-dependent vasodilation after estrogen supplementation. J Am Coll Cardiol. 1997 Oct;30(4):914–919. doi: 10.1016/s0735-1097(97)00234-9. [DOI] [PubMed] [Google Scholar]
  12. Manolio T. A., Furberg C. D., Shemanski L., Psaty B. M., O'Leary D. H., Tracy R. P., Bush T. L. Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. The CHS Collaborative Research Group. Circulation. 1993 Nov;88(5 Pt 1):2163–2171. doi: 10.1161/01.cir.88.5.2163. [DOI] [PubMed] [Google Scholar]
  13. Miller K. L. Hormone replacement therapy in the elderly. Clin Obstet Gynecol. 1996 Dec;39(4):912–932. doi: 10.1097/00003081-199612000-00021. [DOI] [PubMed] [Google Scholar]
  14. Mosca L., Manson J. E., Sutherland S. E., Langer R. D., Manolio T., Barrett-Connor E. Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group. Circulation. 1997 Oct 7;96(7):2468–2482. doi: 10.1161/01.cir.96.7.2468. [DOI] [PubMed] [Google Scholar]
  15. Newton K. M., LaCroix A. Z., McKnight B., Knopp R. H., Siscovick D. S., Heckbert S. R., Weiss N. S. Estrogen replacement therapy and prognosis after first myocardial infarction. Am J Epidemiol. 1997 Feb 1;145(3):269–277. doi: 10.1093/oxfordjournals.aje.a009100. [DOI] [PubMed] [Google Scholar]
  16. O'Keefe J. H., Jr, Kim S. C., Hall R. R., Cochran V. C., Lawhorn S. L., McCallister B. D. Estrogen replacement therapy after coronary angioplasty in women. J Am Coll Cardiol. 1997 Jan;29(1):1–5. doi: 10.1016/s0735-1097(96)00443-3. [DOI] [PubMed] [Google Scholar]
  17. Pines A., Mijatovic V., van der Mooren M. J., Kenemans P. Hormone replacement therapy and cardioprotection: basic concepts and clinical considerations. Eur J Obstet Gynecol Reprod Biol. 1997 Feb;71(2):193–197. doi: 10.1016/s0301-2115(96)02634-6. [DOI] [PubMed] [Google Scholar]
  18. Psaty B. M., Heckbert S. R., Atkins D., Lemaitre R., Koepsell T. D., Wahl P. W., Siscovick D. S., Wagner E. H. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women. Arch Intern Med. 1994 Jun 27;154(12):1333–1339. [PubMed] [Google Scholar]
  19. Rich-Edwards J. W., Manson J. E., Hennekens C. H., Buring J. E. The primary prevention of coronary heart disease in women. N Engl J Med. 1995 Jun 29;332(26):1758–1766. doi: 10.1056/NEJM199506293322607. [DOI] [PubMed] [Google Scholar]
  20. Salamone L. M., Pressman A. R., Seeley D. G., Cauley J. A. Estrogen replacement therapy. A survey of older women's attitudes. Arch Intern Med. 1996 Jun 24;156(12):1293–1297. doi: 10.1001/archinte.156.12.1293. [DOI] [PubMed] [Google Scholar]
  21. Samaan S. A., Crawford M. H. Estrogen and cardiovascular function after menopause. J Am Coll Cardiol. 1995 Nov 15;26(6):1403–1410. doi: 10.1016/0735-1097(95)00360-6. [DOI] [PubMed] [Google Scholar]
  22. Sidney S., Petitti D. B., Quesenberry C. P., Jr Myocardial infarction and the use of estrogen and estrogen-progestogen in postmenopausal women. Ann Intern Med. 1997 Oct 1;127(7):501–508. doi: 10.7326/0003-4819-127-7-199710010-00001. [DOI] [PubMed] [Google Scholar]
  23. Sullivan J. M., El-Zeky F., Vander Zwaag R., Ramanathan K. B. Effect on survival of estrogen replacement therapy after coronary artery bypass grafting. Am J Cardiol. 1997 Apr 1;79(7):847–850. doi: 10.1016/s0002-9149(97)00001-5. [DOI] [PubMed] [Google Scholar]
  24. Sullivan J. M., Vander Zwaag R., Hughes J. P., Maddock V., Kroetz F. W., Ramanathan K. B., Mirvis D. M. Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women. Arch Intern Med. 1990 Dec;150(12):2557–2562. [PubMed] [Google Scholar]
  25. White M. M., Zamudio S., Stevens T., Tyler R., Lindenfeld J., Leslie K., Moore L. G. Estrogen, progesterone, and vascular reactivity: potential cellular mechanisms. Endocr Rev. 1995 Dec;16(6):739–751. doi: 10.1210/edrv-16-6-739. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES